Personalized NK Cell Therapy in CBT
Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive · Acute Biphenotypic Leukemia · Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia in Remission · Acute Myeloid Leukemia With Myelodysplasia-Related Changes · Acute Myeloid Leukemia With Variant MLL Translocations · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · Chemotherapy-Related Leukemia · Chronic Myelomonocytic Leukemia · Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive · High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements · ISS Stage II Plasma Cell Myeloma · ISS Stage III Plasma Cell Myeloma · Myelodysplastic Syndrome · Myelodysplastic Syndrome With Excess Blasts · Myelodysplastic Syndrome With Gene Mutation · Myelodysplastic/Myeloproliferative Neoplasm · Previously Treated Myelodysplastic Syndrome · Recurrent Acute Myeloid Leukemia · Recurrent Adult Acute Myeloid Leukemia · Recurrent Hodgkin Lymphoma · Recurrent Non-Hodgkin Lymphoma · Refractory Acute Lymphoblastic Leukemia · Refractory Adult Acute Lymphoblastic Leukemia · Secondary Acute Myeloid Leukemia · Therapy-Related Myelodysplastic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Warren B Fingrut, MD)
Study leads
Warren Fingrut, MD
Principal Investigator
M.D. Anderson Cancer Center